Makers of Nurofen Plus recall all remaining stock

[dutchman]

The makers of Nurofen Plus have recalled all remaining stock, saying sabotage is suspected in some packets.



Earlier, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert after three packs were found to contain an antipsychotic drug.

Reckitt Benckiser (UK) Ltd said it had heard reports of the wrong drug in two more batches of Nurofen Plus.

A spokesman said the firm was working with police on a formal investigation to find those responsible.

Consumers are advised to return any packs of Nurofen Plus to a pharmacy.

The MHRA issued a safety alert after three packs were found to contain Seroquel XL 50mg. The packs were bought in Victoria, Bromley and Beckenham in south London.

Most people who take one Seroquel will just experience sleepiness, but those on sedatives could feel stronger effects.

Thousands of 32-tablet packs are in the affected batches - numbered 13JJ, 57JJ and 49JJ.

Packs from the three batches - which contain between 4,000 and 7,500 packs each - have been distributed across the UK. But it is known that not all the packs are affected.

Reckitt Benckiser (UK) Ltd said one of the two additional batches affected contained Seroquel XL 50mg, and one contained the Pfizer product Neurontin 100mg capsules, which is an epilepsy drug.

Dr Aomesh Bhatt, medical director for Nurofen Plus, said: "We are taking this matter extremely seriously and have decided to recall all packs of Nurofen Plus as the most prudent course of action in the current circumstances.

"We're asking consumers to return any packs of Nurofen Plus to a pharmacy. No other Nurofen products are affected or being recalled."

A Reckitt Benckiser (UK) Ltd said: "Sabotage is suspected and we are working with the police on a formal investigation to find the person or persons responsible.

"Distribution of Nurofen Plus has been halted at this time."